LEXX RSI Chart
Last 7 days
6.8%
Last 30 days
-36.7%
Last 90 days
65.5%
Trailing 12 Months
7.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 389.7K | 0 | 0 | 0 |
2023 | 343.6K | 337.1K | 226.2K | 279.8K |
2022 | 489.1K | 372.2K | 255.4K | 339.3K |
2021 | 650.3K | 817.9K | 722.7K | 605.9K |
2020 | 406.7K | 250.5K | 252.6K | 495.9K |
2019 | 501.1K | 628.6K | 670.9K | 626.6K |
2018 | 183.5K | 219.3K | 289.1K | 325.8K |
2017 | 48.5K | 68.6K | 64.0K | 113.9K |
2016 | 67.7K | 69.8K | 86.5K | 45.8K |
2015 | 43.7K | 44.8K | 45.9K | 62.6K |
2014 | 863.1K | 394.4K | 159.1K | 42.5K |
2013 | 1.5M | 1.6M | 1.3M | 1.1M |
2012 | 1.1M | 978.6K | 1.1M | 1.4M |
2011 | 555.3K | 748.2K | 941.1K | 1.1M |
2010 | 0 | 0 | 0 | 362.5K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 09, 2023 | turkel catherine c. | bought | 4,266 | 2.8446 | 1,500 | - |
Oct 14, 2022 | downey gregory | bought | 252 | 2.09 | 121 | chief financial officer |
Oct 14, 2022 | downey gregory | acquired | 252 | 2.09 | 121 | chief financial officer |
Oct 13, 2022 | bunka christopher | bought | 34,860 | 2.1 | 16,600 | chief executive officer |
Oct 13, 2022 | bunka christopher | acquired | 34,860 | 2.1 | 16,600 | ceo |
Oct 12, 2022 | bunka christopher | bought | 43,537 | 1.988 | 21,900 | chief executive officer |
Oct 12, 2022 | bunka christopher | acquired | 43,537 | 1.988 | 21,900 | ceo |
May 24, 2022 | reese albert l jr | acquired | 9,790 | 1.958 | 5,000 | - |
May 20, 2022 | reese albert l jr | acquired | 3,610 | 2.007 | 1,799 | - |
May 19, 2022 | reese albert l jr | acquired | 3,017 | 2.01 | 1,501 | - |
Which funds bought or sold LEXX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 25, 2024 | Allworth Financial LP | unchanged | - | 212 | 324 | -% |
Apr 22, 2024 | Oakworth Capital, Inc. | new | - | 18,150 | 18,150 | -% |
Apr 22, 2024 | Raymond James Financial Services Advisors, Inc. | new | - | 143,567 | 143,567 | -% |
Apr 18, 2024 | Aspire Private Capital, LLC | unchanged | - | 952 | 1,452 | -% |
Apr 15, 2024 | Sound Income Strategies, LLC | sold off | -100 | -28.00 | - | -% |
Apr 15, 2024 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | new | - | 37,472 | 37,472 | -% |
Apr 09, 2024 | Welch Group, LLC | new | - | 87,120 | 87,120 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 38.74 | 24,475 | 57,801 | -% |
Feb 15, 2024 | Farther Finance Advisors, LLC | unchanged | - | 42.00 | 208 | -% |
Feb 14, 2024 | CITADEL ADVISORS LLC | new | - | 36,951 | 36,951 | -% |
Unveiling Lexaria Bioscience Corp.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Lexaria Bioscience Corp.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 41.2B | 6.8B | -8.75 | 6.02 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.0B | 1.8B | -41 | 9.87 | ||||
BMRN | 15.4B | 2.5B | 74.73 | 6.21 | ||||
INCY | 11.6B | 3.7B | 19.41 | 3.14 | ||||
MID-CAP | ||||||||
APLS | 6.0B | 396.6M | -11.37 | 15.16 | ||||
BBIO | 4.4B | - | -6.7 | 60.35 | ||||
AXSM | 3.4B | 270.6M | -14.22 | 12.57 | ||||
ACAD | 2.8B | 726.4M | -44.9 | 3.79 | ||||
ARWR | 2.7B | 240.7M | -9.23 | 12.18 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 24.58 | 4.41 | ||||
NVAX | 569.6M | 983.7M | -1.05 | 0.58 | ||||
CRBP | 361.2M | 881.7K | -8.1 | 466.16 | ||||
INO | 247.0M | 4.9M | -1.83 | 50.76 | ||||
IBIO | 6.1M | 2.1M | -0.22 | 2.14 |
Lexaria Bioscience Corp. News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -4.1% | 145 | 151 | 308* | 93.00 | 35.00 | 98.00 | 111 | 100 | 31.00 | 31.00 | 31.00 | 204 | 192 | 296 | 126 | 36.00 | 38.00 | 52.00 | 124 | 193 | 257 |
Gross Profit | -1.0% | 145 | 146 | -3.43 | 80.00 | 32.00 | 82.00 | 70.00 | 81.00 | 24.00 | 8.00 | 11.00 | 144 | 161 | 231 | 134 | 16.00 | -20.56 | 2.00 | 110 | 57.00 | 13.00 |
Operating Expenses | -36.8% | 813 | 1,286 | 1,106 | 2,464 | 1,343 | 1,777 | 818 | 2,499 | 1,473 | 2,012 | 1,313 | 2,711 | 1,266 | 944 | 916 | 1,426 | 1,041 | 979 | 1,226 | 1,245 | 1,166 |
S&GA Expenses | -100.0% | - | 711 | 605 | 823 | 647 | 948 | 462 | 1,747 | 1,197 | 1,553 | 874 | 2,256 | 1,090 | 752 | 3,785 | 55.00 | 61.00 | 74.00 | 90.00 | 82.00 | 52.00 |
R&D Expenses | -57.2% | 246 | 574 | 500 | 1,641 | 696 | 829 | 356 | 752 | 276 | 459 | 440 | 454 | 176 | 192 | 68.00 | 25.00 | 187 | 107 | 162 | 231 | 66.00 |
EBITDA Margin | 27.9% | -5.47* | -7.59* | -9.40* | -6.45* | -6.33* | -6.40* | -8.49* | -5.82* | -4.42* | -3.56* | -2.99* | -2.64* | -3.32* | - | - | - | - | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | 5.00 | - | - | - | 13.00 | - | - | 3.00 | 3.00 | 10.00 | 2.00 | -957* | -27.79 | - | 14.00 |
EBT Margin | 28.2% | -5.83* | -8.12* | -10.04* | -6.74* | -6.61* | -6.70* | -8.89* | -6.10* | -4.64* | -3.75* | -3.14* | -2.78* | -3.49* | - | - | - | - | - | - | - | - |
Net Income | 99.7% | -3.19 | -1,179 | -1,239 | -2,371 | -1,298 | -1,755 | -1,467 | -2,382 | -1,425 | -1,993 | -1,178 | -2,566 | 404 | -696 | -714 | -1,390 | -950 | -907 | -37.73 | -16.13 | -5.13 |
Net Income Margin | 43.5% | -12.30* | -21.76* | -29.46* | -20.45* | -20.09* | -20.73* | -28.46* | -10.84* | -8.25* | -6.66* | -5.59* | -4.37* | -3.69* | - | - | - | - | - | - | - | - |
Free Cashflow | 47.6% | -619 | -1,181 | -1,621 | -1,785 | -1,241 | -1,265 | -1,176 | -1,265 | -1,277 | -1,208 | -1,112 | -1,156 | -911 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 75.1% | 6,352 | 3,627 | 3,084 | 5,240 | 4,855 | 6,213 | 7,834 | 9,138 | 11,415 | 11,746 | 13,267 | 10,548 | 12,172 | 2,174 | 2,828 | 3,320 | 1,986 | 2,746 | 2,675 | 3,457 | 4,274 |
Current Assets | 101.1% | 5,417 | 2,694 | 2,151 | 4,235 | 4,004 | 5,359 | 6,978 | 8,291 | 10,572 | 10,901 | 12,443 | 9,686 | 10,946 | 1,308 | 1,926 | 2,528 | 1,180 | 1,911 | 1,819 | 2,608 | 3,641 |
Cash Equivalents | 140.8% | 4,705 | 1,954 | 1,352 | 3,164 | 3,272 | 4,533 | 5,813 | 7,051 | 8,359 | 9,682 | 10,918 | 8,109 | 9,347 | 525 | 1,294 | 2,034 | 740 | 1,333 | 1,285 | 1,996 | 1,996 |
Inventory | - | - | - | - | - | 8.00 | 10.00 | 38.00 | 40.00 | 32.00 | 27.00 | 30.00 | 52.00 | 137 | 126 | 117 | 133 | 124 | 134 | 127 | 188 | 108 |
Net PPE | -3.1% | 226 | 234 | 254 | 277 | 301 | 311 | 316 | 343 | - | - | 368 | - | 423 | 452 | 483 | 511 | 538 | 565 | 591 | 607 | 433 |
Liabilities | -19.6% | 204 | 254 | 404 | 1,198 | 223 | 282 | 201 | 225 | 195 | 277 | 203 | 281 | 470 | 353 | 346 | 120 | 63.00 | 130 | 185 | 132 | 500 |
Current Liabilities | -34.4% | 82.00 | 125 | 268 | 1,056 | 223 | 282 | 194 | 207 | 166 | 238 | 153 | 221 | 399 | 242 | 226 | 91.00 | 63.00 | 130 | 185 | 132 | 500 |
Shareholder's Equity | 64.3% | 6,148 | 3,742 | 3,044 | 4,395 | 4,632 | 5,932 | 7,632 | 8,913 | 11,220 | 11,469 | 13,064 | 10,266 | 11,703 | 1,821 | 2,482 | 3,201 | 1,923 | 2,615 | 2,491 | 3,325 | 3,773 |
Retained Earnings | -1.4% | -47,592 | -46,942 | -45,763 | -44,524 | -42,152 | -40,854 | -39,098 | -37,631 | -35,248 | -33,822 | -31,829 | - | -28,094 | -28,498 | -27,802 | -27,087 | -25,725 | -24,775 | -23,868 | -22,789 | -21,618 |
Additional Paid-In Capital | 6.8% | 54,121 | 50,671 | 48,799 | 48,912 | 47,121 | 47,110 | 47,041 | 46,809 | 46,697 | 45,498 | 45,089 | 40,990 | 39,860 | 30,373 | 30,324 | 30,184 | 27,525 | 27,221 | 26,172 | 25,891 | 24,319 |
Shares Outstanding | 20.1% | 12,388 | 10,312 | 8,092 | 8,092 | 5,951 | 5,951 | 5,951 | 5,951 | 5,951 | 5,727 | 5,727 | 5,104 | 3,524 | 3,001 | - | - | - | - | - | - | - |
Minority Interest | -0.9% | -372 | -369 | -364 | -354 | -342 | -329 | -316 | -270 | -235 | -212 | -202 | -77.51 | -67.96 | -57.04 | -42.94 | 14.00 | 43.00 | 90.00 | 108 | 145 | 995 |
Float | - | - | - | - | - | 16.20* | - | - | - | 21,000 | - | - | - | 27,000 | - | - | - | 21,566 | - | - | - | 83,889 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 47.6% | -619 | -1,181 | -1,621 | -1,785 | -1,228 | -1,245 | -1,176 | -1,259 | -1,277 | -1,166 | -1,112 | -1,156 | -911 | -809 | -639 | -670 | -753 | -555 | -736 | -1,101 | -603 |
Share Based Compensation | -100.0% | - | 54.00 | 10.00 | 81.00 | 11.00 | 69.00 | 233 | 111 | - | 409 | - | 344 | 17.00 | 49.00 | - | 683 | 294 | 162 | 119 | 443 | - |
Cashflow From Investing | -42.4% | -56.99 | -40.03 | -68.44 | -33.65 | -32.68 | -34.84 | -50.04 | -37.96 | -34.42 | -58.21 | -2* | -70.73 | 270 | -5.77 | -13.64 | -7.49 | -1* | -5.71 | -33.09 | -1,239 | 670 |
Cashflow From Financing | 89.8% | 3,453 | 1,819 | -121 | 1,711 | - | - | -11.20 | -11.20 | -11.20 | -10.99 | 4,004 | -10.99 | 9,435 | -8.77 | -89.15 | 1,916 | 120 | 707 | 59.00 | 1,243 | 381 |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Feb. 29, 2024 | Feb. 28, 2023 | Feb. 29, 2024 | Feb. 28, 2023 | |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) | ||||
Revenue | $ 145,000 | $ 20,025 | $ 296,278 | $ 117,760 |
Cost of goods sold | 0 | 2,958 | 4,822 | 18,753 |
Gross profit | 145,000 | 17,067 | 291,456 | 99,007 |
Operating expenses | ||||
Research and development | 245,779 | 696,178 | 820,270 | 1,525,667 |
General and administrative | 567,226 | 644,514 | 1,278,333 | 1,592,384 |
Total operating expenses | 813,005 | 1,340,692 | 2,098,603 | 3,118,051 |
Loss from operations | (668,005) | (1,323,625) | (1,807,147) | (3,019,044) |
Other income (loss) | ||||
Interest income (expense) | (1) | 14,990 | 7,318 | 18,731 |
Unrealized gain (loss) on marketable securities | 15,273 | (2,003) | (37,942) | (79,631) |
Total other income (loss) | 15,272 | 12,987 | (30,624) | (60,900) |
Net loss | (652,733) | (1,310,638) | (1,837,771) | (3,079,944) |
Less: Net loss attributable to non-controlling interest | (3,194) | (12,507) | (8,909) | (25,869) |
Net loss attributable to Lexaria shareholders | (649,539) | (1,298,131) | (1,828,862) | (3,054,075) |
Other comprehensive loss | ||||
Foreign currency translation adjustment | (24,998) | 0 | (20,626) | 0 |
Total comprehensive loss | $ (674,537) | $ (1,298,131) | $ (1,849,488) | $ (3,054,075) |
Basic and diluted loss per share | $ (0.06) | $ (0.22) | $ (0.18) | $ (0.52) |
Weighted average number of common shares outstanding | ||||
- Basic and diluted | 10,765,143 | 5,950,998 | 9,970,489 | 5,950,998 |
CONSOLIDATED BALANCE SHEETS - USD ($) | Feb. 29, 2024 | Aug. 31, 2023 |
---|---|---|
Current | ||
Cash | $ 4,705,399 | $ 1,352,102 |
Marketable securities | 87,699 | 125,642 |
Accounts receivable | 357,090 | 126,686 |
Prepaid expenses and other current assets | 266,796 | 546,783 |
Total Current Assets | 5,416,984 | 2,151,213 |
Non-current assets, net | ||
Long-term receivables | 39,494 | 48,559 |
Right of use assets | 149,997 | 167,446 |
Intellectual property, net | 519,253 | 462,625 |
Property & equipment, net | 226,315 | 254,143 |
Total Non-current Assets | 935,059 | 932,773 |
TOTAL ASSETS | 6,352,043 | 3,083,986 |
Current Liabilities | ||
Accounts payable and accrued liabilities | 55,318 | 239,941 |
Lease liability, current | 26,399 | 27,794 |
Total Current Liabilities | 81,717 | 267,735 |
Lease liabilities - non-current | 122,486 | 136,173 |
TOTAL LIABILITIES | 204,203 | 403,908 |
Share Capital | ||
Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 12,387,673 and 8,091,650 at February 29, 2024 and August 31, 2023, respectively. | 12,388 | 8,091 |
Additional paid-in capital | 54,121,316 | 48,799,454 |
Accumulated Deficit | (47,592,289) | (45,763,427) |
Accumulated other comprehensive income | (20,626) | 0 |
Equity attributable to shareholders of Lexaria | 6,520,789 | 3,044,118 |
Non-controlling interest | (372,949) | (364,040) |
Total Stockholders' Equity | 6,147,840 | 2,680,078 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 6,352,043 | $ 3,083,986 |